Skip to Content
Merck
  • Activation of the NRF2 antioxidant program sensitizes tumors to G6PD inhibition.

Activation of the NRF2 antioxidant program sensitizes tumors to G6PD inhibition.

Science advances (2021-11-18)
Hongyu Ding, Zihong Chen, Katherine Wu, Shih Ming Huang, Warren L Wu, Sarah E LeBoeuf, Ray G Pillai, Joshua D Rabinowitz, Thales Papagiannakopoulos
ABSTRACT

[Figure: see text].